nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Carnitine—XDH—Procarbazine—brain cancer	0.487	0.671	CbGbCtD
L-Carnitine—MPO—Carboplatin—brain cancer	0.119	0.164	CbGbCtD
L-Carnitine—XDH—Carboplatin—brain cancer	0.119	0.164	CbGbCtD
L-Carnitine—SLC22A8—choroid plexus—brain cancer	0.00927	0.0795	CbGeAlD
L-Carnitine—XDH—Effects of Nitric Oxide—MB—brain cancer	0.009	0.142	CbGpPWpGaD
L-Carnitine—CROT—Peroxisomal lipid metabolism—IDH1—brain cancer	0.00759	0.119	CbGpPWpGaD
L-Carnitine—SLC25A29—ganglion—brain cancer	0.00716	0.0614	CbGeAlD
L-Carnitine—CES1—Phase I biotransformations, non P450—PON1—brain cancer	0.00714	0.112	CbGpPWpGaD
L-Carnitine—CRAT—Peroxisomal lipid metabolism—IDH1—brain cancer	0.00645	0.102	CbGpPWpGaD
L-Carnitine—Fluid overload—Carboplatin—brain cancer	0.0048	0.051	CcSEcCtD
L-Carnitine—SLC22A16—gonad—brain cancer	0.00293	0.0251	CbGeAlD
L-Carnitine—SLC25A29—telencephalon—brain cancer	0.00276	0.0237	CbGeAlD
L-Carnitine—CROT—telencephalon—brain cancer	0.00253	0.0217	CbGeAlD
L-Carnitine—SLC25A29—pituitary gland—brain cancer	0.00225	0.0193	CbGeAlD
L-Carnitine—SLC22A16—endocrine gland—brain cancer	0.00221	0.019	CbGeAlD
L-Carnitine—Gastrointestinal symptom NOS—Hydroxyurea—brain cancer	0.00218	0.0232	CcSEcCtD
L-Carnitine—SLC25A29—medulla oblongata—brain cancer	0.00217	0.0186	CbGeAlD
L-Carnitine—CRAT—telencephalon—brain cancer	0.00214	0.0183	CbGeAlD
L-Carnitine—CES1—E2F transcription factor network—HIC1—brain cancer	0.00206	0.0325	CbGpPWpGaD
L-Carnitine—CROT—pituitary gland—brain cancer	0.00206	0.0177	CbGeAlD
L-Carnitine—SLC25A29—midbrain—brain cancer	0.00198	0.017	CbGeAlD
L-Carnitine—SLC25A29—spinal cord—brain cancer	0.00194	0.0166	CbGeAlD
L-Carnitine—MPO—endothelium—brain cancer	0.00182	0.0156	CbGeAlD
L-Carnitine—CROT—midbrain—brain cancer	0.00182	0.0156	CbGeAlD
L-Carnitine—SLC25A20—pituitary gland—brain cancer	0.0018	0.0154	CbGeAlD
L-Carnitine—CRAT—gonad—brain cancer	0.00179	0.0153	CbGeAlD
L-Carnitine—SLC25A29—endocrine gland—brain cancer	0.00174	0.0149	CbGeAlD
L-Carnitine—CRAT—pituitary gland—brain cancer	0.00174	0.0149	CbGeAlD
L-Carnitine—CPT1A—telencephalon—brain cancer	0.00173	0.0149	CbGeAlD
L-Carnitine—SLC25A20—medulla oblongata—brain cancer	0.00173	0.0149	CbGeAlD
L-Carnitine—SLC25A29—head—brain cancer	0.00172	0.0148	CbGeAlD
L-Carnitine—MPO—blood vessel—brain cancer	0.00168	0.0144	CbGeAlD
L-Carnitine—CRAT—medulla oblongata—brain cancer	0.00168	0.0144	CbGeAlD
L-Carnitine—Myasthenia—Carmustine—brain cancer	0.00165	0.0175	CcSEcCtD
L-Carnitine—Melaena—Procarbazine—brain cancer	0.00162	0.0172	CcSEcCtD
L-Carnitine—CPT1A—AMPK Signaling—STRADA—brain cancer	0.00161	0.0253	CbGpPWpGaD
L-Carnitine—CROT—endocrine gland—brain cancer	0.0016	0.0137	CbGeAlD
L-Carnitine—SLC25A20—midbrain—brain cancer	0.00158	0.0136	CbGeAlD
L-Carnitine—CROT—head—brain cancer	0.00158	0.0135	CbGeAlD
L-Carnitine—SLC25A29—central nervous system—brain cancer	0.00157	0.0135	CbGeAlD
L-Carnitine—SLC25A20—spinal cord—brain cancer	0.00154	0.0132	CbGeAlD
L-Carnitine—CRAT—midbrain—brain cancer	0.00154	0.0132	CbGeAlD
L-Carnitine—SLC25A29—cerebellum—brain cancer	0.00154	0.0132	CbGeAlD
L-Carnitine—CRAT—spinal cord—brain cancer	0.0015	0.0129	CbGeAlD
L-Carnitine—CPT1A—gonad—brain cancer	0.00145	0.0124	CbGeAlD
L-Carnitine—CROT—central nervous system—brain cancer	0.00144	0.0124	CbGeAlD
L-Carnitine—Renal failure—Lomustine—brain cancer	0.00144	0.0153	CcSEcCtD
L-Carnitine—CROT—cerebellum—brain cancer	0.00141	0.0121	CbGeAlD
L-Carnitine—SLC25A20—endocrine gland—brain cancer	0.00139	0.0119	CbGeAlD
L-Carnitine—CPT2—gonad—brain cancer	0.00137	0.0118	CbGeAlD
L-Carnitine—SLC25A20—head—brain cancer	0.00137	0.0118	CbGeAlD
L-Carnitine—CPT2—PPAR Alpha Pathway—CDK4—brain cancer	0.00135	0.0213	CbGpPWpGaD
L-Carnitine—CRAT—endocrine gland—brain cancer	0.00135	0.0116	CbGeAlD
L-Carnitine—CPT2—pituitary gland—brain cancer	0.00134	0.0115	CbGeAlD
L-Carnitine—CRAT—head—brain cancer	0.00133	0.0114	CbGeAlD
L-Carnitine—Haemoglobin—Lomustine—brain cancer	0.00132	0.014	CcSEcCtD
L-Carnitine—Haemorrhage—Lomustine—brain cancer	0.00131	0.0139	CcSEcCtD
L-Carnitine—CPT2—medulla oblongata—brain cancer	0.00129	0.0111	CbGeAlD
L-Carnitine—SLC25A20—central nervous system—brain cancer	0.00125	0.0107	CbGeAlD
L-Carnitine—SLC25A29—brain—brain cancer	0.00125	0.0107	CbGeAlD
L-Carnitine—SLC25A20—cerebellum—brain cancer	0.00122	0.0105	CbGeAlD
L-Carnitine—CRAT—central nervous system—brain cancer	0.00122	0.0104	CbGeAlD
L-Carnitine—CRAT—cerebellum—brain cancer	0.00119	0.0102	CbGeAlD
L-Carnitine—CPT2—midbrain—brain cancer	0.00118	0.0101	CbGeAlD
L-Carnitine—CES1—Irinotecan Pathway—APC—brain cancer	0.00118	0.0185	CbGpPWpGaD
L-Carnitine—Accidental injury—Carmustine—brain cancer	0.00117	0.0125	CcSEcCtD
L-Carnitine—CPT2—spinal cord—brain cancer	0.00115	0.00989	CbGeAlD
L-Carnitine—CROT—brain—brain cancer	0.00114	0.00981	CbGeAlD
L-Carnitine—CPT1A—endocrine gland—brain cancer	0.00109	0.00938	CbGeAlD
L-Carnitine—CPT1A—head—brain cancer	0.00108	0.00926	CbGeAlD
L-Carnitine—Infection—Carboplatin—brain cancer	0.00106	0.0112	CcSEcCtD
L-Carnitine—CPT2—endocrine gland—brain cancer	0.00104	0.0089	CbGeAlD
L-Carnitine—Injection site reaction—Carmustine—brain cancer	0.00103	0.011	CcSEcCtD
L-Carnitine—CPT2—head—brain cancer	0.00102	0.00879	CbGeAlD
L-Carnitine—SLC25A20—brain—brain cancer	0.000995	0.00853	CbGeAlD
L-Carnitine—CRAT—brain—brain cancer	0.000965	0.00828	CbGeAlD
L-Carnitine—CPT1A—cerebellum—brain cancer	0.000963	0.00826	CbGeAlD
L-Carnitine—CPT1A—PPAR Alpha Pathway—CDK4—brain cancer	0.000936	0.0147	CbGpPWpGaD
L-Carnitine—CPT2—central nervous system—brain cancer	0.000935	0.00802	CbGeAlD
L-Carnitine—Infection—Lomustine—brain cancer	0.000926	0.00983	CcSEcCtD
L-Carnitine—CPT2—cerebellum—brain cancer	0.000914	0.00784	CbGeAlD
L-Carnitine—Cardiovascular disorder—Etoposide—brain cancer	0.000913	0.0097	CcSEcCtD
L-Carnitine—Pain—Carboplatin—brain cancer	0.000911	0.00967	CcSEcCtD
L-Carnitine—Anorexia—Lomustine—brain cancer	0.000889	0.00943	CcSEcCtD
L-Carnitine—CPT2—PPAR Alpha Pathway—CCND1—brain cancer	0.000872	0.0137	CbGpPWpGaD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—HES5—brain cancer	0.000861	0.0136	CbGpPWpGaD
L-Carnitine—Body temperature increased—Carboplatin—brain cancer	0.000842	0.00894	CcSEcCtD
L-Carnitine—Haemoglobin—Procarbazine—brain cancer	0.000837	0.00889	CcSEcCtD
L-Carnitine—Haemorrhage—Procarbazine—brain cancer	0.000833	0.00884	CcSEcCtD
L-Carnitine—Injury—Carmustine—brain cancer	0.00082	0.0087	CcSEcCtD
L-Carnitine—Decreased appetite—Lomustine—brain cancer	0.00081	0.0086	CcSEcCtD
L-Carnitine—XDH—endocrine gland—brain cancer	0.000808	0.00693	CbGeAlD
L-Carnitine—CPT1A—brain—brain cancer	0.000782	0.00671	CbGeAlD
L-Carnitine—Arrhythmia—Procarbazine—brain cancer	0.000744	0.0079	CcSEcCtD
L-Carnitine—CPT2—brain—brain cancer	0.000742	0.00637	CbGeAlD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000741	0.0117	CbGpPWpGaD
L-Carnitine—Body temperature increased—Lomustine—brain cancer	0.000737	0.00782	CcSEcCtD
L-Carnitine—Weight increased—Hydroxyurea—brain cancer	0.000733	0.00778	CcSEcCtD
L-Carnitine—CPT1A—Circadian rythm related genes—NTRK3—brain cancer	0.000726	0.0114	CbGpPWpGaD
L-Carnitine—XDH—Oxidative Stress—SOD2—brain cancer	0.000704	0.0111	CbGpPWpGaD
L-Carnitine—CPT2—PPAR Alpha Pathway—MYC—brain cancer	0.000699	0.011	CbGpPWpGaD
L-Carnitine—Anaemia—Procarbazine—brain cancer	0.00067	0.00711	CcSEcCtD
L-Carnitine—Muscular weakness—Carmustine—brain cancer	0.000664	0.00705	CcSEcCtD
L-Carnitine—MPO—pituitary gland—brain cancer	0.000664	0.0057	CbGeAlD
L-Carnitine—Haemoglobin—Hydroxyurea—brain cancer	0.000648	0.00688	CcSEcCtD
L-Carnitine—Haemorrhage—Hydroxyurea—brain cancer	0.000645	0.00684	CcSEcCtD
L-Carnitine—Muscular weakness—Temozolomide—brain cancer	0.000642	0.00682	CcSEcCtD
L-Carnitine—Cough—Procarbazine—brain cancer	0.000633	0.00672	CcSEcCtD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.00063	0.00992	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.00063	0.00992	CbGpPWpGaD
L-Carnitine—Convulsion—Procarbazine—brain cancer	0.000628	0.00667	CcSEcCtD
L-Carnitine—Hypertension—Procarbazine—brain cancer	0.000626	0.00665	CcSEcCtD
L-Carnitine—Myalgia—Procarbazine—brain cancer	0.000617	0.00655	CcSEcCtD
L-Carnitine—CES1—endocrine gland—brain cancer	0.000616	0.00529	CbGeAlD
L-Carnitine—Anxiety—Procarbazine—brain cancer	0.000615	0.00653	CcSEcCtD
L-Carnitine—CES1—head—brain cancer	0.000608	0.00522	CbGeAlD
L-Carnitine—SLC22A4—pituitary gland—brain cancer	0.000607	0.0052	CbGeAlD
L-Carnitine—Bronchitis—Temozolomide—brain cancer	0.000605	0.00642	CcSEcCtD
L-Carnitine—CPT1A—PPAR Alpha Pathway—CCND1—brain cancer	0.000604	0.00951	CbGpPWpGaD
L-Carnitine—Vomiting—Lomustine—brain cancer	0.000593	0.00629	CcSEcCtD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—S100A10—brain cancer	0.000589	0.00928	CbGpPWpGaD
L-Carnitine—Infection—Procarbazine—brain cancer	0.000588	0.00624	CcSEcCtD
L-Carnitine—Angiopathy—Hydroxyurea—brain cancer	0.000585	0.00621	CcSEcCtD
L-Carnitine—Depression—Carmustine—brain cancer	0.000579	0.00615	CcSEcCtD
L-Carnitine—Tachycardia—Procarbazine—brain cancer	0.000578	0.00613	CcSEcCtD
L-Carnitine—Weight increased—Temozolomide—brain cancer	0.000573	0.00608	CcSEcCtD
L-Carnitine—MPO—spinal cord—brain cancer	0.000572	0.0049	CbGeAlD
L-Carnitine—Renal failure—Carmustine—brain cancer	0.000571	0.00606	CcSEcCtD
L-Carnitine—Weight decreased—Temozolomide—brain cancer	0.000569	0.00604	CcSEcCtD
L-Carnitine—Urinary tract infection—Carmustine—brain cancer	0.000564	0.00599	CcSEcCtD
L-Carnitine—Anorexia—Procarbazine—brain cancer	0.000564	0.00599	CcSEcCtD
L-Carnitine—Depression—Temozolomide—brain cancer	0.000559	0.00594	CcSEcCtD
L-Carnitine—CES1—central nervous system—brain cancer	0.000555	0.00476	CbGeAlD
L-Carnitine—Nausea—Lomustine—brain cancer	0.000554	0.00588	CcSEcCtD
L-Carnitine—Hypotension—Procarbazine—brain cancer	0.000553	0.00587	CcSEcCtD
L-Carnitine—Urinary tract infection—Temozolomide—brain cancer	0.000545	0.00579	CcSEcCtD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000542	0.00853	CbGpPWpGaD
L-Carnitine—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000539	0.00572	CcSEcCtD
L-Carnitine—Insomnia—Procarbazine—brain cancer	0.000535	0.00568	CcSEcCtD
L-Carnitine—Paraesthesia—Procarbazine—brain cancer	0.000531	0.00564	CcSEcCtD
L-Carnitine—SLCO1B1—endocrine gland—brain cancer	0.00053	0.00454	CbGeAlD
L-Carnitine—MPO—Vitamin B12 Metabolism—SOD2—brain cancer	0.000527	0.00829	CbGpPWpGaD
L-Carnitine—Sinusitis—Temozolomide—brain cancer	0.000526	0.00559	CcSEcCtD
L-Carnitine—Haemoglobin—Carmustine—brain cancer	0.000524	0.00556	CcSEcCtD
L-Carnitine—SLC22A4—spinal cord—brain cancer	0.000522	0.00448	CbGeAlD
L-Carnitine—Haemorrhage—Carmustine—brain cancer	0.000521	0.00553	CcSEcCtD
L-Carnitine—Anaemia—Hydroxyurea—brain cancer	0.000519	0.00551	CcSEcCtD
L-Carnitine—MPO—endocrine gland—brain cancer	0.000515	0.00441	CbGeAlD
L-Carnitine—Decreased appetite—Procarbazine—brain cancer	0.000514	0.00546	CcSEcCtD
L-Carnitine—Oedema peripheral—Carmustine—brain cancer	0.000513	0.00545	CcSEcCtD
L-Carnitine—MPO—head—brain cancer	0.000508	0.00436	CbGeAlD
L-Carnitine—Haemoglobin—Temozolomide—brain cancer	0.000506	0.00537	CcSEcCtD
L-Carnitine—Constipation—Procarbazine—brain cancer	0.000506	0.00537	CcSEcCtD
L-Carnitine—Pain—Procarbazine—brain cancer	0.000506	0.00537	CcSEcCtD
L-Carnitine—SLCO1B1—Irinotecan Pathway—APC—brain cancer	0.000504	0.00793	CbGpPWpGaD
L-Carnitine—Haemorrhage—Temozolomide—brain cancer	0.000504	0.00535	CcSEcCtD
L-Carnitine—Pharyngitis—Temozolomide—brain cancer	0.0005	0.00531	CcSEcCtD
L-Carnitine—Oedema peripheral—Temozolomide—brain cancer	0.000496	0.00527	CcSEcCtD
L-Carnitine—Eye disorder—Carmustine—brain cancer	0.000487	0.00517	CcSEcCtD
L-Carnitine—Convulsion—Hydroxyurea—brain cancer	0.000486	0.00516	CcSEcCtD
L-Carnitine—CPT1A—PPAR Alpha Pathway—MYC—brain cancer	0.000485	0.00763	CbGpPWpGaD
L-Carnitine—Gastrointestinal pain—Procarbazine—brain cancer	0.000484	0.00514	CcSEcCtD
L-Carnitine—MPO—C-MYB transcription factor network—CDK6—brain cancer	0.000481	0.00757	CbGpPWpGaD
L-Carnitine—Eye disorder—Temozolomide—brain cancer	0.000471	0.005	CcSEcCtD
L-Carnitine—Body temperature increased—Procarbazine—brain cancer	0.000468	0.00497	CcSEcCtD
L-Carnitine—Abdominal pain—Procarbazine—brain cancer	0.000468	0.00497	CcSEcCtD
L-Carnitine—Arrhythmia—Carmustine—brain cancer	0.000466	0.00494	CcSEcCtD
L-Carnitine—MPO—central nervous system—brain cancer	0.000464	0.00398	CbGeAlD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000461	0.00725	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000461	0.00725	CbGpPWpGaD
L-Carnitine—Angiopathy—Temozolomide—brain cancer	0.000457	0.00485	CcSEcCtD
L-Carnitine—Infection—Hydroxyurea—brain cancer	0.000455	0.00483	CcSEcCtD
L-Carnitine—CES1—E2F transcription factor network—SIRT1—brain cancer	0.000442	0.00695	CbGpPWpGaD
L-Carnitine—Renal failure—Etoposide—brain cancer	0.000441	0.00468	CcSEcCtD
L-Carnitine—CES1—brain—brain cancer	0.000441	0.00378	CbGeAlD
L-Carnitine—Back pain—Carmustine—brain cancer	0.000439	0.00466	CcSEcCtD
L-Carnitine—Anorexia—Hydroxyurea—brain cancer	0.000437	0.00463	CcSEcCtD
L-Carnitine—CES1—E2F transcription factor network—CCNE1—brain cancer	0.000436	0.00687	CbGpPWpGaD
L-Carnitine—Hypersensitivity—Procarbazine—brain cancer	0.000436	0.00463	CcSEcCtD
L-Carnitine—Dysgeusia—Temozolomide—brain cancer	0.000429	0.00456	CcSEcCtD
L-Carnitine—MPO—Folate Metabolism—SOD2—brain cancer	0.000428	0.00674	CbGpPWpGaD
L-Carnitine—Asthenia—Procarbazine—brain cancer	0.000425	0.00451	CcSEcCtD
L-Carnitine—Back pain—Temozolomide—brain cancer	0.000424	0.0045	CcSEcCtD
L-Carnitine—Anaemia—Carmustine—brain cancer	0.000419	0.00445	CcSEcCtD
L-Carnitine—Pruritus—Procarbazine—brain cancer	0.000419	0.00444	CcSEcCtD
L-Carnitine—SLC22A4—cerebellum—brain cancer	0.000414	0.00355	CbGeAlD
L-Carnitine—Dyspnoea—Hydroxyurea—brain cancer	0.000408	0.00433	CcSEcCtD
L-Carnitine—SLC22A8—head—brain cancer	0.000406	0.00348	CbGeAlD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000406	0.00639	CbGpPWpGaD
L-Carnitine—Anaemia—Temozolomide—brain cancer	0.000405	0.0043	CcSEcCtD
L-Carnitine—Diarrhoea—Procarbazine—brain cancer	0.000405	0.0043	CcSEcCtD
L-Carnitine—CPT1A—AMPK Signaling—PIK3CG—brain cancer	0.000404	0.00635	CbGpPWpGaD
L-Carnitine—Dyspepsia—Hydroxyurea—brain cancer	0.000403	0.00428	CcSEcCtD
L-Carnitine—SLC22A5—pituitary gland—brain cancer	0.000401	0.00344	CbGeAlD
L-Carnitine—Decreased appetite—Hydroxyurea—brain cancer	0.000398	0.00423	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000395	0.0042	CcSEcCtD
L-Carnitine—Vertigo—Temozolomide—brain cancer	0.000394	0.00418	CcSEcCtD
L-Carnitine—MPO—IL23-mediated signaling events—RELA—brain cancer	0.000393	0.00619	CbGpPWpGaD
L-Carnitine—Convulsion—Carmustine—brain cancer	0.000393	0.00417	CcSEcCtD
L-Carnitine—Hypertension—Carmustine—brain cancer	0.000392	0.00416	CcSEcCtD
L-Carnitine—Pain—Hydroxyurea—brain cancer	0.000392	0.00416	CcSEcCtD
L-Carnitine—Constipation—Hydroxyurea—brain cancer	0.000392	0.00416	CcSEcCtD
L-Carnitine—Dizziness—Procarbazine—brain cancer	0.000391	0.00415	CcSEcCtD
L-Carnitine—Palpitations—Temozolomide—brain cancer	0.000387	0.00411	CcSEcCtD
L-Carnitine—SLC22A5—medulla oblongata—brain cancer	0.000387	0.00332	CbGeAlD
L-Carnitine—Myalgia—Carmustine—brain cancer	0.000386	0.0041	CcSEcCtD
L-Carnitine—Chest pain—Carmustine—brain cancer	0.000386	0.0041	CcSEcCtD
L-Carnitine—Anxiety—Carmustine—brain cancer	0.000385	0.00409	CcSEcCtD
L-Carnitine—Cough—Temozolomide—brain cancer	0.000383	0.00406	CcSEcCtD
L-Carnitine—Convulsion—Temozolomide—brain cancer	0.00038	0.00403	CcSEcCtD
L-Carnitine—Hypertension—Temozolomide—brain cancer	0.000379	0.00402	CcSEcCtD
L-Carnitine—Eye disorder—Etoposide—brain cancer	0.000377	0.004	CcSEcCtD
L-Carnitine—Vomiting—Procarbazine—brain cancer	0.000376	0.00399	CcSEcCtD
L-Carnitine—Myalgia—Temozolomide—brain cancer	0.000373	0.00396	CcSEcCtD
L-Carnitine—Rash—Procarbazine—brain cancer	0.000373	0.00396	CcSEcCtD
L-Carnitine—Dermatitis—Procarbazine—brain cancer	0.000373	0.00396	CcSEcCtD
L-Carnitine—Anxiety—Temozolomide—brain cancer	0.000372	0.00395	CcSEcCtD
L-Carnitine—SLC22A8—central nervous system—brain cancer	0.000371	0.00318	CbGeAlD
L-Carnitine—Headache—Procarbazine—brain cancer	0.000371	0.00394	CcSEcCtD
L-Carnitine—MPO—brain—brain cancer	0.000368	0.00316	CbGeAlD
L-Carnitine—Infection—Carmustine—brain cancer	0.000368	0.0039	CcSEcCtD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—ESR2—brain cancer	0.000366	0.00577	CbGpPWpGaD
L-Carnitine—Angiopathy—Etoposide—brain cancer	0.000366	0.00388	CcSEcCtD
L-Carnitine—Body temperature increased—Hydroxyurea—brain cancer	0.000362	0.00384	CcSEcCtD
L-Carnitine—Tachycardia—Carmustine—brain cancer	0.000361	0.00384	CcSEcCtD
L-Carnitine—Infection—Temozolomide—brain cancer	0.000355	0.00377	CcSEcCtD
L-Carnitine—MPO—IL23-mediated signaling events—IL2—brain cancer	0.000354	0.00558	CbGpPWpGaD
L-Carnitine—SLC22A5—midbrain—brain cancer	0.000354	0.00304	CbGeAlD
L-Carnitine—MPO—C-MYB transcription factor network—HES1—brain cancer	0.000354	0.00557	CbGpPWpGaD
L-Carnitine—Anorexia—Carmustine—brain cancer	0.000353	0.00375	CcSEcCtD
L-Carnitine—Nausea—Procarbazine—brain cancer	0.000352	0.00373	CcSEcCtD
L-Carnitine—Hypotension—Carmustine—brain cancer	0.000346	0.00367	CcSEcCtD
L-Carnitine—SLC22A5—spinal cord—brain cancer	0.000345	0.00296	CbGeAlD
L-Carnitine—Dysgeusia—Etoposide—brain cancer	0.000344	0.00365	CcSEcCtD
L-Carnitine—Anorexia—Temozolomide—brain cancer	0.000341	0.00362	CcSEcCtD
L-Carnitine—MPO—Selenium Micronutrient Network—SOD2—brain cancer	0.00034	0.00536	CbGpPWpGaD
L-Carnitine—Back pain—Etoposide—brain cancer	0.000339	0.0036	CcSEcCtD
L-Carnitine—Hypersensitivity—Hydroxyurea—brain cancer	0.000337	0.00358	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Carmustine—brain cancer	0.000337	0.00358	CcSEcCtD
L-Carnitine—Muscle spasms—Etoposide—brain cancer	0.000337	0.00358	CcSEcCtD
L-Carnitine—SLC22A4—brain—brain cancer	0.000336	0.00288	CbGeAlD
L-Carnitine—Insomnia—Carmustine—brain cancer	0.000335	0.00355	CcSEcCtD
L-Carnitine—Paraesthesia—Carmustine—brain cancer	0.000332	0.00353	CcSEcCtD
L-Carnitine—Dyspnoea—Carmustine—brain cancer	0.00033	0.0035	CcSEcCtD
L-Carnitine—CROT—Metabolism—CYP2C9—brain cancer	0.00033	0.00519	CbGpPWpGaD
L-Carnitine—Asthenia—Hydroxyurea—brain cancer	0.000329	0.00349	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000326	0.00346	CcSEcCtD
L-Carnitine—Anaemia—Etoposide—brain cancer	0.000324	0.00344	CcSEcCtD
L-Carnitine—Insomnia—Temozolomide—brain cancer	0.000324	0.00344	CcSEcCtD
L-Carnitine—Decreased appetite—Carmustine—brain cancer	0.000322	0.00342	CcSEcCtD
L-Carnitine—Paraesthesia—Temozolomide—brain cancer	0.000321	0.00341	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Carmustine—brain cancer	0.00032	0.00339	CcSEcCtD
L-Carnitine—Dyspnoea—Temozolomide—brain cancer	0.000319	0.00339	CcSEcCtD
L-Carnitine—Pain—Carmustine—brain cancer	0.000317	0.00336	CcSEcCtD
L-Carnitine—Constipation—Carmustine—brain cancer	0.000317	0.00336	CcSEcCtD
L-Carnitine—Vertigo—Etoposide—brain cancer	0.000315	0.00335	CcSEcCtD
L-Carnitine—Dyspepsia—Temozolomide—brain cancer	0.000315	0.00334	CcSEcCtD
L-Carnitine—Diarrhoea—Hydroxyurea—brain cancer	0.000313	0.00333	CcSEcCtD
L-Carnitine—Decreased appetite—Temozolomide—brain cancer	0.000311	0.0033	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Temozolomide—brain cancer	0.000309	0.00328	CcSEcCtD
L-Carnitine—Cough—Etoposide—brain cancer	0.000306	0.00325	CcSEcCtD
L-Carnitine—Pain—Temozolomide—brain cancer	0.000306	0.00325	CcSEcCtD
L-Carnitine—Constipation—Temozolomide—brain cancer	0.000306	0.00325	CcSEcCtD
L-Carnitine—MPO—Vitamin B12 Metabolism—RELA—brain cancer	0.000304	0.00479	CbGpPWpGaD
L-Carnitine—Convulsion—Etoposide—brain cancer	0.000304	0.00323	CcSEcCtD
L-Carnitine—Hypertension—Etoposide—brain cancer	0.000303	0.00322	CcSEcCtD
L-Carnitine—Dizziness—Hydroxyurea—brain cancer	0.000303	0.00322	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Carmustine—brain cancer	0.000303	0.00321	CcSEcCtD
L-Carnitine—Chest pain—Etoposide—brain cancer	0.000299	0.00317	CcSEcCtD
L-Carnitine—MPO—IL23-mediated signaling events—STAT3—brain cancer	0.000298	0.00469	CbGpPWpGaD
L-Carnitine—XDH—Selenium Micronutrient Network—SOD2—brain cancer	0.000297	0.00468	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000297	0.00467	CbGpPWpGaD
L-Carnitine—SLC22A8—brain—brain cancer	0.000294	0.00252	CbGeAlD
L-Carnitine—Body temperature increased—Carmustine—brain cancer	0.000293	0.00311	CcSEcCtD
L-Carnitine—Abdominal pain—Carmustine—brain cancer	0.000293	0.00311	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Temozolomide—brain cancer	0.000293	0.00311	CcSEcCtD
L-Carnitine—Vomiting—Hydroxyurea—brain cancer	0.000291	0.00309	CcSEcCtD
L-Carnitine—Rash—Hydroxyurea—brain cancer	0.000289	0.00307	CcSEcCtD
L-Carnitine—Dermatitis—Hydroxyurea—brain cancer	0.000289	0.00306	CcSEcCtD
L-Carnitine—Headache—Hydroxyurea—brain cancer	0.000287	0.00305	CcSEcCtD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—HES1—brain cancer	0.000285	0.00448	CbGpPWpGaD
L-Carnitine—Infection—Etoposide—brain cancer	0.000284	0.00302	CcSEcCtD
L-Carnitine—Abdominal pain—Temozolomide—brain cancer	0.000283	0.003	CcSEcCtD
L-Carnitine—Body temperature increased—Temozolomide—brain cancer	0.000283	0.003	CcSEcCtD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000281	0.00443	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—CYP2C9—brain cancer	0.000281	0.00442	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—CYP2C9—brain cancer	0.000281	0.00442	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—BSG—brain cancer	0.000281	0.00442	CbGpPWpGaD
L-Carnitine—Tachycardia—Etoposide—brain cancer	0.000279	0.00297	CcSEcCtD
L-Carnitine—SLC22A5—cerebellum—brain cancer	0.000274	0.00235	CbGeAlD
L-Carnitine—Anorexia—Etoposide—brain cancer	0.000273	0.0029	CcSEcCtD
L-Carnitine—Hypersensitivity—Carmustine—brain cancer	0.000273	0.0029	CcSEcCtD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000272	0.00428	CbGpPWpGaD
L-Carnitine—Nausea—Hydroxyurea—brain cancer	0.000272	0.00289	CcSEcCtD
L-Carnitine—CES1—Fluoropyrimidine Activity—TP53—brain cancer	0.000268	0.00422	CbGpPWpGaD
L-Carnitine—Hypotension—Etoposide—brain cancer	0.000268	0.00284	CcSEcCtD
L-Carnitine—Asthenia—Carmustine—brain cancer	0.000266	0.00282	CcSEcCtD
L-Carnitine—Hypersensitivity—Temozolomide—brain cancer	0.000264	0.0028	CcSEcCtD
L-Carnitine—Paraesthesia—Etoposide—brain cancer	0.000257	0.00273	CcSEcCtD
L-Carnitine—Asthenia—Temozolomide—brain cancer	0.000257	0.00273	CcSEcCtD
L-Carnitine—CES1—E2F transcription factor network—CDKN2A—brain cancer	0.000255	0.00402	CbGpPWpGaD
L-Carnitine—Dyspnoea—Etoposide—brain cancer	0.000255	0.00271	CcSEcCtD
L-Carnitine—Diarrhoea—Carmustine—brain cancer	0.000253	0.00269	CcSEcCtD
L-Carnitine—Pruritus—Temozolomide—brain cancer	0.000253	0.00269	CcSEcCtD
L-Carnitine—Decreased appetite—Etoposide—brain cancer	0.000249	0.00264	CcSEcCtD
L-Carnitine—MPO—Folate Metabolism—RELA—brain cancer	0.000248	0.0039	CbGpPWpGaD
L-Carnitine—Gastrointestinal disorder—Etoposide—brain cancer	0.000247	0.00262	CcSEcCtD
L-Carnitine—Dizziness—Carmustine—brain cancer	0.000245	0.0026	CcSEcCtD
L-Carnitine—Constipation—Etoposide—brain cancer	0.000245	0.0026	CcSEcCtD
L-Carnitine—Pain—Etoposide—brain cancer	0.000245	0.0026	CcSEcCtD
L-Carnitine—Diarrhoea—Temozolomide—brain cancer	0.000245	0.0026	CcSEcCtD
L-Carnitine—CROT—Metabolism—IDH1—brain cancer	0.000241	0.0038	CbGpPWpGaD
L-Carnitine—CPT1A—Circadian rythm related genes—SIRT1—brain cancer	0.000241	0.00379	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—BSG—brain cancer	0.000239	0.00376	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—BSG—brain cancer	0.000239	0.00376	CbGpPWpGaD
L-Carnitine—Dizziness—Temozolomide—brain cancer	0.000237	0.00251	CcSEcCtD
L-Carnitine—Vomiting—Carmustine—brain cancer	0.000235	0.0025	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Etoposide—brain cancer	0.000234	0.00249	CcSEcCtD
L-Carnitine—Rash—Carmustine—brain cancer	0.000233	0.00248	CcSEcCtD
L-Carnitine—Dermatitis—Carmustine—brain cancer	0.000233	0.00248	CcSEcCtD
L-Carnitine—Headache—Carmustine—brain cancer	0.000232	0.00246	CcSEcCtD
L-Carnitine—Vomiting—Temozolomide—brain cancer	0.000227	0.00242	CcSEcCtD
L-Carnitine—Abdominal pain—Etoposide—brain cancer	0.000226	0.0024	CcSEcCtD
L-Carnitine—Body temperature increased—Etoposide—brain cancer	0.000226	0.0024	CcSEcCtD
L-Carnitine—Rash—Temozolomide—brain cancer	0.000226	0.00239	CcSEcCtD
L-Carnitine—Dermatitis—Temozolomide—brain cancer	0.000225	0.00239	CcSEcCtD
L-Carnitine—Headache—Temozolomide—brain cancer	0.000224	0.00238	CcSEcCtD
L-Carnitine—MPO—Folate Metabolism—IL2—brain cancer	0.000223	0.00351	CbGpPWpGaD
L-Carnitine—SLC22A5—brain—brain cancer	0.000223	0.00191	CbGeAlD
L-Carnitine—Nausea—Carmustine—brain cancer	0.00022	0.00233	CcSEcCtD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—S100A10—brain cancer	0.000218	0.00343	CbGpPWpGaD
L-Carnitine—Nausea—Temozolomide—brain cancer	0.000213	0.00226	CcSEcCtD
L-Carnitine—MPO—C-MYB transcription factor network—CDKN2A—brain cancer	0.000212	0.00334	CbGpPWpGaD
L-Carnitine—Hypersensitivity—Etoposide—brain cancer	0.000211	0.00224	CcSEcCtD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000206	0.00324	CbGpPWpGaD
L-Carnitine—Asthenia—Etoposide—brain cancer	0.000205	0.00218	CcSEcCtD
L-Carnitine—SLC25A20—Metabolism—IDH1—brain cancer	0.000205	0.00323	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—IDH1—brain cancer	0.000205	0.00323	CbGpPWpGaD
L-Carnitine—Pruritus—Etoposide—brain cancer	0.000203	0.00215	CcSEcCtD
L-Carnitine—MPO—Selenium Micronutrient Network—RELA—brain cancer	0.000197	0.0031	CbGpPWpGaD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	0.000196	0.00309	CbGpPWpGaD
L-Carnitine—Diarrhoea—Etoposide—brain cancer	0.000196	0.00208	CcSEcCtD
L-Carnitine—CROT—Metabolism—ENO2—brain cancer	0.000191	0.003	CbGpPWpGaD
L-Carnitine—Dizziness—Etoposide—brain cancer	0.000189	0.00201	CcSEcCtD
L-Carnitine—CPT1A—AMPK Signaling—TP53—brain cancer	0.000182	0.00287	CbGpPWpGaD
L-Carnitine—CPT1A—Circadian rythm related genes—CDK4—brain cancer	0.000182	0.00287	CbGpPWpGaD
L-Carnitine—Vomiting—Etoposide—brain cancer	0.000182	0.00193	CcSEcCtD
L-Carnitine—CPT2—Metabolism—CYP2C9—brain cancer	0.000181	0.00285	CbGpPWpGaD
L-Carnitine—Rash—Etoposide—brain cancer	0.000181	0.00192	CcSEcCtD
L-Carnitine—Dermatitis—Etoposide—brain cancer	0.00018	0.00191	CcSEcCtD
L-Carnitine—Headache—Etoposide—brain cancer	0.000179	0.0019	CcSEcCtD
L-Carnitine—MPO—C-MYB transcription factor network—CCND1—brain cancer	0.000179	0.00282	CbGpPWpGaD
L-Carnitine—CES1—E2F transcription factor network—MYC—brain cancer	0.000173	0.00272	CbGpPWpGaD
L-Carnitine—XDH—Selenium Micronutrient Network—RELA—brain cancer	0.000172	0.00271	CbGpPWpGaD
L-Carnitine—Nausea—Etoposide—brain cancer	0.00017	0.00181	CcSEcCtD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	0.000167	0.00263	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	0.000167	0.00263	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—S100A10—brain cancer	0.000164	0.00258	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—ENO2—brain cancer	0.000162	0.00255	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—ENO2—brain cancer	0.000162	0.00255	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—BSG—brain cancer	0.000154	0.00242	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—S100A10—brain cancer	0.000148	0.00233	CbGpPWpGaD
L-Carnitine—MPO—C-MYB transcription factor network—MYC—brain cancer	0.000144	0.00226	CbGpPWpGaD
L-Carnitine—MPO—Folate Metabolism—TP53—brain cancer	0.000143	0.00225	CbGpPWpGaD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—CTNNB1—brain cancer	0.000143	0.00225	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—IDH1—brain cancer	0.000132	0.00208	CbGpPWpGaD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—VEGFA—brain cancer	0.000126	0.00198	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—CYP2C9—brain cancer	0.000125	0.00197	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—S100A10—brain cancer	0.000113	0.00177	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	0.000108	0.00169	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—BSG—brain cancer	0.000107	0.00168	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—ENO2—brain cancer	0.000105	0.00164	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000101	0.00159	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	9.81e-05	0.00154	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—IDH1—brain cancer	9.16e-05	0.00144	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—PIK3CG—brain cancer	8.75e-05	0.00138	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CYP2C9—brain cancer	8.3e-05	0.00131	CbGpPWpGaD
L-Carnitine—CPT1A—Circadian rythm related genes—TP53—brain cancer	7.75e-05	0.00122	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—TRPC6—brain cancer	7.57e-05	0.00119	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	7.46e-05	0.00117	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PIK3CG—brain cancer	7.44e-05	0.00117	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PIK3CG—brain cancer	7.44e-05	0.00117	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—ENO2—brain cancer	7.24e-05	0.00114	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	7.17e-05	0.00113	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—BSG—brain cancer	7.06e-05	0.00111	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—TRPC6—brain cancer	6.85e-05	0.00108	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—IDH1—brain cancer	6.07e-05	0.000955	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—TRPC6—brain cancer	5.2e-05	0.000818	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—ENO2—brain cancer	4.8e-05	0.000755	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PIK3CG—brain cancer	4.79e-05	0.000755	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CYP2C9—brain cancer	4.37e-05	0.000688	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—BSG—brain cancer	3.72e-05	0.000585	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PIK3CG—brain cancer	3.32e-05	0.000523	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—IDH1—brain cancer	3.19e-05	0.000503	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.6e-05	0.000409	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ENO2—brain cancer	2.53e-05	0.000397	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PIK3CG—brain cancer	2.2e-05	0.000346	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PIK3CG—brain cancer	1.16e-05	0.000182	CbGpPWpGaD
